G Pavlinkova

Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts.

G W Beresford, S. Batra, D. Colcher, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: improved biodistribution and potential for therapeutic application.

S. Batra, J. Baranowska-Kortylewicz, D. Colcher, 2000, Cancer research.

Pharmacokinetics and biodistribution of genetically engineered antibodies.

S. Batra, Maneesh Jain, A. Choudhury, 2002, Current opinion in biotechnology.

99mTc-labeled divalent and tetravalent CC49 single-chain Fv's: novel imaging agents for rapid in vivo localization of human colon carcinoma.

S. Batra, S. Hinrichs, J. Baranowska-Kortylewicz, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Binding characteristics and tumor targeting of a covalently linked divalent CC49 single‐chain antibody

G W Beresford, S. Batra, D. Colcher, 1999, International journal of cancer.

Divalent forms of CC49 single-chain antibody constructs in Pichia pastoris: expression, purification, and characterization.

G W Beresford, S. Batra, J. Baranowska-Kortylewicz, 2000, Journal of biochemistry.